Methylergonovine maleate 0.2mg/mL; amp. IM: 0.2mg after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium; may be repeated as required at intervals of 2–4 ...

The tablets are used for the prevention and management of postpartum hemorrhage (PPH), a condition characterized by excessive bleeding during labor. Lupin has bolstered its portfolio by introducing ...

BALTIMORE — Lupin on Thursday announced that it would be re-introducing its Methergine (methylergonovine maleate) tablets. The drug is indicated to manage uterine atony, hemorrhage and subinvolution ...

Lupin and its US subsidiary have re-introduced Methergine (methylergonovine maleate) oral tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only ...

Drug firm Lupin has strengthened its brand portfolio in the US market with the introduction of its Methergine oral tablets used for the prevention and management of excess blood loss after delivery, ...

Drug firm Lupin has strengthened its brand portfolio in the US market with the introduction of its Methergine oral tablets used for the prevention and management of excess blood loss after delivery, ...

Granules Pharmaceutical, the U.S. subsidiary of Granules india, has received Food and Drug Administration approval for its generic Methergine tablets (methylergonovine tablets). The drug is indicated ...

(RTTNews) - Hikma Pharmaceuticals PLC (HIK.L) announced that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp., has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic ...

Granules India Ltd today said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership with West-Ward Pharmaceuticals Corp, a wholly-owned ...